European regulators greenlight AZ's Nexium combo

AstraZeneca's ($AZN) Nexium-plus-aspirin combo, dubbed Axanum, got the nod from European regulators. The company says it's working to get the drug onto formularies there as soon as possible. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.